AMPLATZER Membranous VSD Occluder

· Abbott Medical Devices

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMPLATZER Membranous VSD Occluder, covering 2019-02-04 to 2019-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER [Phase 1]